Literature DB >> 6304226

Frequencies of the separate human B cell subsets activatable to Ig secretion by Epstein-Barr virus and pokeweed mitogen.

O Martínez-Maza, S Britton.   

Abstract

We have developed a microculture system suitable for limiting dilution analysis of Epstein-Barr virus (EBV)- and pokeweed mitogen (PWM)-induced activation of immunoglobulin secretion by human B cells. It was found that exogenous filler cells were not required to obtain optimal EBV-induced B cell precursor frequency (PF) estimates, although filler T cells were required for optimal PWM activation. In fact, when autologous T cells were used as filler cells, a marked decrease in the EBV-induced IgM PF was noted. Treatment of the T cells with cyclosporin A partially eliminated, and irradiation of the T cells completely eliminated, this decrease. The calculated PF of B cells activated by EBV was from 1/290 to 1/3,700 for IgM, and from 1/920 to 1/3,250 for IgG secretion. PWM activated from 1/140 to 1/3,200 B cells to IgM secretion. The results of experiments in which EBV and PWM were mixed, indicated that these two polyclonal activators operated on different B cell subpopulations. Therefore, both these agents seem to activate small, discrete subpopulations of human peripheral blood B cells to Ig secretion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304226      PMCID: PMC2187062          DOI: 10.1084/jem.157.6.1808

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

1.  A live human B-cell activator operating in isolation of other cellular influences.

Authors:  A G Bird; S Britton
Journal:  Scand J Immunol       Date:  1979       Impact factor: 3.487

Review 2.  A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator.

Authors:  A G Bird; S Britton
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  IgG on human blood lymphocytes studied by immunofluorescence.

Authors:  D Pettersson; H Mellstedt; G Holm
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

4.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

Review 5.  Various forms of Epstein-Barr virus infection in man: established facts and a general concept.

Authors:  M A Epstein; B G Achong
Journal:  Lancet       Date:  1973-10-13       Impact factor: 79.321

6.  A plaque assay for all cells secreting Ig of a given type or class.

Authors:  E Gronowicz; A Coutinho; F Melchers
Journal:  Eur J Immunol       Date:  1976-08       Impact factor: 5.532

7.  Clonal growth and maturation to immunoglobulin secretion in vitro of every growth-inducible B lymphocyte.

Authors:  J Andersson; A Coutinho; W Lernhardt; F Melchers
Journal:  Cell       Date:  1977-01       Impact factor: 41.582

8.  Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis.

Authors:  V Diehl; G Henle; W Henle; G Kohn
Journal:  J Virol       Date:  1968-07       Impact factor: 5.103

9.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

10.  Comparison of the yield of infectious virus from clones of human and simian lymphoblastoid lines transformed by Epstein-Barr virus.

Authors:  G Miller; M Lipman
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

View more
  16 in total

Review 1.  Human B lymphocytes mature.

Authors:  J Gordon
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

Review 2.  B cell clones in rheumatoid arthritis.

Authors:  M Steinitz
Journal:  Springer Semin Immunopathol       Date:  1988

3.  Pathways of human B-lymphocyte activation blocked by B-cell specific monoclonal antibodies.

Authors:  J T Golay; D H Crawford
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

4.  Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma.

Authors:  Marta Epeldegui; Otoniel Martínez-Maza
Journal:  For Immunopathol Dis Therap       Date:  2015

5.  Humoral immune deficiency in multiple myeloma patients due to compromised B-cell function.

Authors:  L M Pilarski; E J Andrews; M J Mant; B A Ruether
Journal:  J Clin Immunol       Date:  1986-11       Impact factor: 8.317

6.  Abnormal function of B lymphocytes from peripheral blood of multiple myeloma patients. Lack of correlation between the number of cells potentially able to secrete immunoglobulin M and serum immunoglobulin M levels.

Authors:  L M Pilarski; B A Ruether; M J Mant
Journal:  J Clin Invest       Date:  1985-06       Impact factor: 14.808

7.  Monospecific but not polyreactive human hybridoma rheumatoid factors exhibit preferential binding specificities for IgG3 and IgG4.

Authors:  M M Newkirk; J Rauch
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

Review 8.  Human monoclonal antibodies.

Authors:  S P Cole; B G Campling; T Atlaw; D Kozbor; J C Roder
Journal:  Mol Cell Biochem       Date:  1984-06       Impact factor: 3.396

9.  Human IgG Fc-binding phage antibodies constructed from synovial fluid CD38+ B cells of patients with rheumatoid arthritis show the imprints of an antigen-dependent process of somatic hypermutation and clonal selection.

Authors:  W J E Van Esch; C C Reparon-Schuijt; H J Hamstra; C Van Kooten; T Logtenberg; F C Breedveld; C L Verweij
Journal:  Clin Exp Immunol       Date:  2003-02       Impact factor: 4.330

10.  Circulating activated B cells in primary biliary cirrhosis.

Authors:  S P James; E A Jones; J H Hoofnagle; W Strober
Journal:  J Clin Immunol       Date:  1985-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.